Kalbe Farma KLBF IJ -Buy- Transforming the brand
Consumer health is a very crucial division for KLBF, as it possesses the highest margin,
Consumer Durables SH JW SC 354 3rd Mar, 2025
Affordable while luxury: all-time high market share in biscuits and wafers
We believe the middle-income class continues to prefer value-for-money FMCG products, given the lack of government incentives; the lower-end group will likely consume more affordable but branded FMCG products on the back of higher disposable income amid higher soft commodity selling prices as well as an increased number of social aid programs (read Follow the money). Hence, we believe MYOR’s product portfolio is in a sweet spot to enjoy higher demand, backed by its competitive pricing (20-30% GPM), strong brand value (market share domination), and quality products with global standards (45% of sales is contributed by exports). In fact, the company improved its market share in 2024 in biscuits and wafers categories by ~100bp. MYOR’s biscuits market share reached 43% in FY24 (vs 42% in FY23 and 28% in FY14); we expect growth in market share to continue, gaining from local and foreign brands (see Fig. 2). MYOR’s wafers division recorded a 24% market share in FY24 (vs 23% in FY23 and 6% in FY14); the company’s wafers have been successfully gaining market share from major incumbents such as Orang Tua Group (unlisted). Higher market share also translated to record-high processed food sales in 4Q24, up by +18% y-y.
Blessing in disguise: coffee market share surges in the Philippines
Expensive coffee bean prices put pressure on margins, but, this situation allowed MYOR to expand market share significantly in the instant coffee segment due to a better pricing strategy. We note that MYOR’s market share rose from 45% in FY23 to 49% in FY24 in the Philippines, as the company gained market share significantly after Universal Robina Corp (URC PM, Not rated) and Nestle (NESN SW, Not rated) raised their prices aggressively from 1Q24. This new market base should sustain or even may expand further, in our view; historically, MYOR has maintained its market leadership position in the Philippines over the past eight years (see Fig. 4). A surge in instant coffee market share in the Philippines was also reflected in all-time high sales for MYOR’s beverages segment in 4Q24.
Input cost pressure is a temporary phase
We believe coffee and cocoa prices are the company’s main concerns related to earnings growth in 2025. The company may not pass on the price increases on time, which may affect profitability in the short term. However, it is a temporary issue, in our view; historically, ASP adjustment has covered increasing raw material costs, given the company’s pricing power (see Fig. 8). On top of that, we believe the company can maintain its low A&P-to-sales ratio, backed by its strong brand equity.
Maintain Buy call; double-digit domestic and export sales growth in 2M25
MYOR recorded all-time high sales in 4Q24, thanks to both domestic and export sales. GPM in 4Q24 was better q-q basis due to ASP adjustment. Overall 4Q24 results were in line with market expectations. We think strong sales performance should resume this year. Our industry survey shows that MYOR could record double-digit sales growth in the domestic market even after the high base last year during the presidential election in Feb-24. Moreover, exports sales also recorded double-digit sales growth due to ASEAN’s contribution. We maintain our Buy call with a TP of IDR4,300, using a target P/E of 26.5x FY25F (+0.2SD to its five-year mean). Downside risks would be higher-than-expected coffee and cocoa costs.
INVESTMENT RATINGS
A rating of ‘Buy’, indicates that the analyst expects the stock to outperform the Benchmark over the next 12 months. A rating of ‘Neutral’, indicates that the analyst expects the stock to perform in line with the Benchmark over the next 12 months. A rating of ‘Reduce’, indicates that the analyst expects the stock to underperform the Benchmark over the next 12 months. A rating of ‘Suspended’, indicates that the rating, target price, and estimates have been suspended temporarily to comply with applicable regulations and/or firm policies. Securities and/or companies that are labelled as ‘Not Rated’ or ‘No Rating’ are not in regular research coverage. Benchmark is Indonesia Composite Index (‘IDX Composite’). A ‘Target Price’, if discussed, indicates the analyst’s forecast for the share price with a 12-month time horizon, reflecting in part of the analyst’s estimates for the company’s earnings, and may be impeded by general market and macroeconomic trends, and by other risks related to the company or the market in general.
GENERAL DISCLOSURE/DISCLAIMER
This report is prepared by PT Verdhana Sekuritas Indonesia (“PTVSI”) a securities company registered in Indonesia, supervised by Indonesia Financial Services Authority (OJK) and a member of the Indonesia Stock Exchange (IDX).
This report is intended for client of PTVSI only and no part of this document may be (i) copied, photocopied or duplicated in any form or by any means or (ii) redistributed without the prior written consent of PTVSI.
The research set out in this report is based on information obtained from sources believed to be reliable, but PTVSI do not make any representation or warranty as to its accuracy, completeness or correctness. The information in this report is subject to change without notice, its accuracy is not guaranteed, it may be incomplete or condensed and it may not contain all material information concerning the company (or companies) referred to in this report. Any information, valuations, opinions, estimates, forecasts, ratings or targets herein constitutes a judgment as of the date of this report is published, and there is no assurance that future results or events will be consistent.
This report is not to be construed as an offer or a solicitation of an offer to buy or sell any securities or financial products. PTVSI and its associates, its directors, and/or its employees may from time to time have interests in the securities mentioned in this report or it may or will engage in any securities transaction or other capital market services for the company (companies) mentioned herein.
ANALYST CERTIFICATION
The research analyst primarily responsible for the content of this report and certifies that the views about the companies including their securities expressed in this report accurately reflect his/her personal views. The analyst also certifies that no part of his/her compensation was, is, or will be, directly, or indirectly, related to specific recommendations or views expressed in this report.
RESTRICTIONS ON DISTRIBUTION
By accepting this report, the recipient hereof represents and warrants that you are entitled to receive such report in accordance with the restrictions and agrees to be bound by the limitations contained herein. Neither this report nor any copy hereof may be distributed except in compliance with applicable Indonesian capital market laws and regulations.
Rating Remains | Buy |
Target price Remains | IDR 4,300 |
Closing price 28 February 2025 | IDR 2,120 |
Sandy Ham (sandy.ham@verdhana.id)
Jody Wijaya (jody.wijaya@verdhana.id)
Samuel Christian (samuel.christian@verdhana.id)